Results 41 to 50 of about 623,477 (179)

Coronavirus infection in chemosensory cells

Journal of NeuroVirology, 2023
Clinical manifestations of human coronavirus (HCoV)-related diseases are mostly related to the respiratory system, although secondary complications such as headache, anosmia, ageusia, and myalgia have been reported. HCoV infection and replication in chemosensory cells associated with ageusia and anosmia is poorly understood. Here, we characterized HCoV-
Martina Donadoni, Rafal Kaminski, Shuren Liao, Suhair Al Janabi, Robert F. Margolskee, Mehmet Hakan Ozdener, Ilker K. Sariyer   +6 more
openaire   +2 more sources

Emerging viral respiratory tract infections—environmental risk factors and transmission [PDF]

, 2014
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Charrel, Remi N., Gautret, Philippe, Gray, Gregory C., Memish, Ziad A., Odezulu, Nnanyelugo G., Zumla, Alimuddin   +6 more
core   +1 more source

Neurologic complications of coronavirus infections [PDF]

Neurology, 2020
In 1896, Sir William Osler1 said, “Humanity has but three great enemies: fever, famine, and war; of these by far the greatest, by far the most terrible, is fever.” This rings true even today.
openaire   +2 more sources

NLR, CRP, LDH as severity markers in Coronavirus Positive patients

National Board of Examinations Journal of Medical Sciences, 2023
Background: Coronavirus is a deadly respiratory virus and was discovered way back in 1965 but made a recent comeback in November- December 2019. In March 2020, coronavirus infection was declared a pandemic, since then there has been widespread research ...
Pulkit Jindal, Preetmohinder Kaur
doaj   +1 more source

Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns [PDF]

, 2016
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A., Omrani, Ali S.   +2 more
core   +1 more source

N-glycoproteomic profiling revealing novel coronavirus therapeutic targets potentially involved in Cepharanthine's intervention

Medicine in Novel Technology and Devices, 2022
The Coronavirus disease 2019 (COVID-19) has posed a serious threat to global health and the world economy. Antiviral therapies targeting coronavirus are urgently required. The Cepharanthine (CEP) is a traditional Chinese herbal extract.
Wenlin An, Fengjuan Tian, Jing Li, Junge Chen, Yigang Tong   +4 more
doaj   +1 more source

The SARS-coronavirus-host interactome [PDF]

, 2011
Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to ...
Brunn, Albrecht von, Carbajo-Lozoya, Javier, Dall'Armi, Ekatarina von, Ditt, Vanessa, Drosten, Christian, Friedel, Caroline C., Haas, Juergen G., Herrler, Georg, Herzog, Petra, Hilgenfeld, Rolf, Kallies, Stefan, Kuri, Thomas, Kögl, Manfred, Müller, Marcel A., Niemeyer, Daniela, Pfefferle, Susanne, Pumpor, Ksenia, Pöhlmann, Stefan, Schwarz, Frank, Schwegmann-Wessels, Christel, Schöpf, Julia, Steffen, Imke, Stellberger, Thorsten, Thiel, Heinz-Jürgen, Thiel, Volker, Weber, Friedemann, Zimmer, Ralf, Züst, Roland   +27 more
core   +1 more source

Seizures associated with coronavirus infections [PDF]

Seizure, 2020
Neurotropic and neuroinvasive capabilities of coronaviruses have been described in humans. Neurological problems found in patients with coronavirus infection include: febrile seizures, convulsions, loss of consciousness, encephalomyelitis, and encephalitis. Coronavirus disease (COVID-19) is caused by SARS-CoV2.
openaire   +2 more sources

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis

Immunity, Inflammation and Disease, 2021
Objective To provide the latest evidence for the efficacy and safety of arbidol (umifenovir) in COVID‐19 treatment. Methods A literature systematic search was carried out in PubMed, Cochrane Library, Embase, and medRxiv up to May 2021.
Behnam Amani, Bahman Amani, Sara Zareei, Mahsa Zareei   +3 more
doaj   +1 more source

Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality

Critical Care Explorations, 2021
Objectives:. To investigate the differences in clinical course, ventilator mechanics, and outcomes of patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection compared with a historical cohort of acute respiratory
Alaa Abu Sayf, MD, Raef Fadel, DO, Ashley Scott, MD, Layla Al Bizri, MD, Wing Tai Kong, MD, Mohamed Rezik, DO, Katherine Joyce, MD, Yusuf Alalwan, MD, Mohamed Dabaja, MD, Sashi Nair, MD, Krishna Modi, , MD, Indira Brar, , MD, Geehan Suleyman, MD, Jennifer Swiderek, MD, Geneva Tatem, MD, Joseph Miller, MD, Gillian Grafton, DO, Daniel R. Ouellette, MD   +17 more
doaj   +1 more source